AJNA BioSciences

About

AJNA BioSciences is a pharmaceutical company based in Littleton, Colorado, that focuses on developing FDA-approved botanical drugs for central nervous system disorders. Founded in 2021, the company combines traditional plant medicine with modern pharmaceutical science to create clinically validated treatments. As a public benefit corporation, AJNA BioSciences employs fewer than 25 people and operates a 13,500 square-foot headquarters in Denver, equipped for rapid drug discovery and development. The company specializes in areas such as Chemistry, Manufacturing, and Controls (CMC), and is supported by a team of elite medical researchers in neurology and psychiatry. AJNA BioSciences is developing treatments for Autism Spectrum Disorder, Generalized Anxiety Disorder, and Post-Traumatic Stress Disorder, with its lead product, AJA001, targeting autism symptoms. This oral multi-cannabinoid botanical drug has received FDA Investigational New Drug application clearance and is advancing to Phase 2 clinical trials. AJNA BioSciences aims to provide natural pharmaceutical options for patients and healthcare providers seeking alternatives to conventional medications.